![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Seegene Debuts Automated Development for Molecular Testing Devices
Seegene Debuts Automated Development for Molecular Testing Devices
Seegene has developed a in silico-based solution for automated development of molecular testing devices, the company revealed Wednesday.
The automated solution can reduce assay development time significantly, down to less than a week.
By using an in silico-based development solution, Seegene has found a way to simplify the process of real-time PCR assay development and is looking to expand its use in molecular diagnostics, the company disclosed. — Cynthia Jessup
Upcoming Events
-
21Oct